Search

Your search keyword '"Chelidonium chemistry"' showing total 99 results

Search Constraints

Start Over You searched for: Descriptor "Chelidonium chemistry" Remove constraint Descriptor: "Chelidonium chemistry"
99 results on '"Chelidonium chemistry"'

Search Results

1. The Synergistic Mechanism of Chelidonium majus Alkaloids on Melanoma Treatment via a Multi-Strategy Insight.

2. Screening of Chelidonium majus isoquinoline alkaloids reveals berberine and chelidonine as selective ligands for the nuclear receptors RORβ and HNF4α, respectively.

Catalog

Books, media, physical & digital resources

3. Novel Approaches for the Analysis and Isolation of Benzylisoquinoline Alkaloids in Chelidonium majus.

4. Evaluation of the in vitro and in vivo antimicrobial activity of alkaloids prepared from Chelidonium majus L. using MRSA- infected C. elegans as a model host.

5. Chemical characterization of three different extracts obtained from Chelidonium majus L. (Greater celandine) with insights into their in vitro, in silico and network pharmacological properties.

6. The Greater Celandine: Identification and Characterization of an Antimicrobial Peptide from Chelidonium majus .

7. Determination of Selected Isoquinoline Alkaloids from Chelidonium majus , Mahonia aquifolium and Sanguinaria canadensis Extracts by Liquid Chromatography and Their In Vitro and In Vivo Cytotoxic Activity against Human Cancer Cells.

8. The Activity of Chelidonium majus L. Latex and Its Components on HPV Reveal Insights into the Antiviral Molecular Mechanism.

9. Eutectic Thin-Layer Chromatography as a New Possibility for Quantification of Plant Extracts-A Case Study.

10. Synthesis and characterization of chitosan nanoparticles loaded with greater celandine (Chelidonium majus L.) essential oil as an anticancer agent on MCF-7 cell line.

11. Combined Protein and Alkaloid Research of Chelidonium majus Latex Reveals CmMLP1 Accompanied by Alkaloids with Cytotoxic Potential to Human Cervical Carcinoma Cells.

12. Greater celandine (Chelidonium majus L.) for COVID-19: A twenty-case series.

13. Enantioselective Syntheses of Strychnos and Chelidonium Alkaloids through Regio- and Stereocontrolled Cooperative Catalysis.

14. Thin-layer chromatography with eutectic mobile phases-preliminary results.

15. Milky Sap of Greater Celandine ( Chelidonium majus L.) and Anti-Viral Properties.

16. Modulatory Effect of Chelidonium majus Extract and Its Alkaloids on LPS-Stimulated Cytokine Secretion in Human Neutrophils.

17. New lignanamides and alkaloids from Chelidonium majus and their anti-inflammation activity.

18. Protoberberine compounds extracted from Chelidonium majus L. as novel natural photosensitizers for cancer therapy.

19. Applicability of a Monolithic Column for Separation of Isoquinoline Alkalodis from Chelidonium majus Extract.

20. Comparison of Anticancer Activity and HPLC-DAD Determination of Selected Isoquinoline Alkaloids from Thalictrum foetidum , Berberis sp. and Chelidonium majus Extracts.

21. Characterization of the cytotoxicity of selected Chelidonium alkaloids in rat hepatocytes.

22. Development of a Selective Adsorbing Material for Binding of Pyrrolizidine Alkaloids in Herbal Extracts, Based on Molecular Group Imprinting.

23. Cytotoxic and Proapoptotic Activity of Sanguinarine, Berberine, and Extracts of Chelidonium majus L. and Berberis thunbergii DC. toward Hematopoietic Cancer Cell Lines.

24. Hypolipidemic effects of herbal extracts by reduction of adipocyte differentiation, intracellular neutral lipid content, lipolysis, fatty acid exchange and lipid droplet motility.

25. Intracellular Accumulation as an Indicator of Cytotoxicity to Screen Hepatotoxic Components of Chelidonium majus L. by LC-MS/MS.

26. Polyaniline based material as a new SPE sorbent for pre-treatment of Chelidonium majus extracts before chromatographic analysis of alkaloids.

27. Impact of drought and salt stress on the biosynthesis of alkaloids in Chelidonium majus L.

28. Enrichment of chelidonine from Chelidonium majus L. using macroporous resin and its antifungal activity.

29. Six scalemic mixtures of 6-monosubstituted dihydrobenzophenanthridine alkaloids from Chelidonium majus and optically active structures of enantiomers.

30. Cytotoxic and antimicrobial effects of biosynthesized ZnO nanoparticles using of Chelidonium majus extract.

31. Isolation and characterization of a non-specific lipid transfer protein from Chelidonium majus L. latex.

32. Larvicidal activity and insecticidal mechanism of Chelidonium majus on Lymantria dispar.

33. Selectivity of major isoquinoline alkaloids from Chelidonium majus towards telomeric G-quadruplex: A study using a transition-FRET (t-FRET) assay.

34. Defense-related Proteins from Chelidonium majus L. as Important Components of its Latex.

35. Chelidonium majus crude extract inhibits migration and induces cell cycle arrest and apoptosis in tumor cell lines.

36. Optimization of a novel chelerythrine-loaded magnetic Fe3 O4 /chitosan alpha-ketoglutaric acid system and evaluation of its anti-tumour activities.

37. Comparative cytotoxicity of chelidonine and homochelidonine, the dimethoxy analogues isolated from Chelidonium majus L. (Papaveraceae), against human leukemic and lung carcinoma cells.

38. In vitro and in vivo investigations on the antitumour activity of Chelidonium majus.

39. Chelidonine, a principal isoquinoline alkaloid of Chelidonium majus, attenuates eosinophilic airway inflammation by suppressing IL-4 and eotaxin-2 expression in asthmatic mice.

40. Anti-malarial effect of semi-synthetic drug amitozyn.

41. 13,14-dihydrocoptisine--the genuine alkaloid from Chelidonium majus.

42. Chelidonium majus L. extract induces apoptosis through caspase activity via MAPK-independent NF-κB signaling in human epidermoid carcinoma A431 cells.

43. Effects of Chelidonium majus extracts and major alkaloids on hERG potassium channels and on dog cardiac action potential - a safety approach.

44. Box-Behnken factorial design to obtain a phenolic-rich extract from the aerial parts of Chelidonium majus L.

45. Combining metabolomic analysis and microarray gene expression analysis in the characterization of the medicinal plant Chelidonium majus L.

46. Global proteomic analysis of Chelidonium majus and Corydalis cava (Papaveraceae) extracts revealed similar defense-related protein compositions.

47. One new alkaloid from Chelidonium majus L.

48. Poly (lactide-co-glycolide) nano-encapsulation of chelidonine, an active bioingredient of greater celandine (Chelidonium majus), enhances its ameliorative potential against cadmium induced oxidative stress and hepatic injury in mice.

49. Capillary electrophoretic study of the synergistic biological effects of alkaloids from Chelidonium majus L. in normal and cancer cells.

50. [Study on the separation process of pharmacological active total alkaloids from Chelidonium majus L. growing in Georgia].